Patient Management with Stable Ischemic Heart Disease, An Issue of Medical Clinics of North America

1st Edition, Volume 108-3 - March 28, 2024
Editors: Alexander Fanaroff, John W. Hirshfeld Jr
Language: English
Hardback ISBN:
9 7 8 - 0 - 4 4 3 - 2 9 3 6 8 - 9
eBook ISBN:
9 7 8 - 0 - 4 4 3 - 2 9 3 6 9 - 6

In this issue of Medical Clinics of North America, guest editors Drs. Alexander Fanaroff and John W. Hirschfeld, Jr., bring their considerable expertise to the topic of Patien… Read more

Patient Management with Stable Ischemic Heart Disease, An Issue of Medical Clinics of North America

Purchase options

Info / Buy

Limited Offer

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code needed.

Institutional subscription on ScienceDirect

Request a sales quote

In this issue of Medical Clinics of North America, guest editors Drs. Alexander Fanaroff and John W. Hirschfeld, Jr., bring their considerable expertise to the topic of Patient Management with Stable Ischemic Heart Disease. Top experts provide insights into newer diagnostic modalities for patients presenting with symptoms of stable ischemic heart disease, review the pillars of medical management as well as emerging cardiometabolic therapies, provide updates on the role of revascularization, and reveal gender, racial, ethnic, and socioeconomic disparities in the presentation and management of stable ischemic heart disease.

Cover image
Title page
Table of Contents
Copyright
CME Accreditation Page
Forthcoming Issues
Contributors
Foreword
Preface
The Pathophysiologic Basis of Managing Chronic Atherosclerotic Cardiovascular Disease
Key points
Introduction/background
Atherosclerosis prevention/attenuation
Coronary disease recognition,“staging” and severity assessment
Management of symptoms caused by coronary atherosclerosis
Prevention of atherothrombosis
Prevention and management of end-organ complications
Summary and clinics care points
Diagnosing Coronary Artery Disease in the Patient Presenting with Stable Ischemic Heart Disease: The Role of Anatomic versus Functional Testing
Key points
Introduction/history/definitions/background
Discussion
Summary
Clinics care points
Optimal Medical Therapy for Stable Ischemic Heart Disease in 2024: Focus on Blood Pressure and Lipids
Key points
Hypertension and coronary artery disease
Effect of hypertension on adverse cardiovascular outcomes
Low-density lipoprotein cholesterol and coronary artery disease
Triglycerides and stable coronary artery disease
Summary
Clinics care points
Optimal Medical Therapy for Stable Ischemic Heart Disease: Focus on Anti-anginal Therapy
Key points
Introduction
Pathophysiology
Common options for medical therapy
Ischemia with no obstructive coronary arteries
Summary
A New Age for Secondary Prevention: Optimal Medical Therapy for Stable Ischemic Heart Disease Among Patients with Diabetes and/or Obesity
Key points
Background
Summary
Clinics care points
Optimal Medical Therapy for Chronic Coronary Disease in 2024: Focus on Antithrombotic Therapy
Key points
Introduction
Rationale for antithrombotic therapy in secondary prevention
Aspirin
P2Y12 inhibitors
Anticoagulants
Translating evidence to clinical practice
Guideline recommendations
Summary
Clinics care points
Optimal Medical Therapy for Stable Ischemic Heart Disease in 2024: Focus on Exercise and Cardiac Rehabilitation
Key points
Introduction
Benefits of cardiac rehabilitation
Patient assessment
Exercise training
Lifestyle management and behavioral modification
Alternative modalities of cardiac rehabilitation
Changes to cardiac rehabilitation because of the coronavirus disease 2019 pandemic
Summary
Clinics care points
Funding
When to Consider Coronary Revascularization for Stable Coronary Artery Disease
Key points
Introduction
Case presentation
Discussion
Revascularization to reduce mortality
Revascularization to improve other cardiovascular outcomes
Revascularization to improve symptoms
Revascularization strategy: Percutaneous coronary intervention versus coronary artery bypass grafting
Controversies and unanswered questions
Case decision-making and resolution
Summary
Antiplatelet Therapy for Patients Who Have Undergone Revascularization Within the Past Year: Which Agents and for How Long?
Key points
Introduction
Dual antiplatelet therapy: current agents and rationale of use after revascularization
Clinical practice guidelines on antiplatelet therapy after revascularization
Bleeding and ischemic risk assessment
Antithrombotic strategies
Dual antiplatelet therapy
Monotherapy with P2Y12 inhibitors
Dual pathway inhibition
High bleeding risk patient
Antithrombotic framework
Summary
Clinics care points
Medical Decision-Making and Revascularization in Ischemic Cardiomyopathy
Key points
Introduction
Definition of ischemic cardiomyopathy
Epidemiology, clinical characteristics, and outcomes
Pathophysiology of ischemic cardiomyopathy
Diagnostic evaluation of ischemia in heart failure
Management of ischemic cardiomyopathy
Areas of controversy and topics of future investigation
Summary and integrating evidence into clinical practice
Clinics care points
Ischemic Heart Disease in Women
Key points
Introduction
Biologic differences
Risk factors
Presentation
Pathophysiology
Summary
Clinics care points
Chronic Coronary Disease in Older Adults
Key points
Introduction
Discussion
Future directions
Summary
Clinics care points
Racial and Ethnic Disparities in the Management of Chronic Coronary Disease
Key points
Introduction
Terminology
Diversity in clinical trials
Disparities in Non-invasive Management
Guideline-directed medical therapy for chronic coronary disease
Cardiac Rehabilitation
Disparities in invasive management and outcomes
Addressing disparities and conclusions
Clinics care point
Funding

Life sciences

Physical sciences & Engineering

Social sciences & Humanities

Health

Patient Management with Stable Ischemic Heart Disease, An Issue of Medical Clinics of North America

Purchase options

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code needed.

Institutional subscription on ScienceDirect

Alexander Fanaroff

John W. Hirshfeld Jr